Lasix
Replacement
|
Medicines
|
15/07/2011
The marketing authorization holder informed its supplied customers in a letter dated July 7, 2011, that another batch that had exceeded the 18-month shelf life would be replaced. Already on April 12, 2011, batches were withdrawn from the market after it had to be determined that the occurrence of visible particles is possible if the runtime of 18 months is exceeded.
| Name of the medicinal product | Lasix 250 mg - Konzentrat zur Infusion |
|---|---|
| Marketing authorisation number(s) | 15.861 |
| Marketing authorisation holder | Sanofi-aventis GmbH |
| Batch number(s) | 0F001A |
| Classification of the recall | I |
| BASG reference number | INS-640.001-0096 |
Further inquiry note
Page last modified:
12/07/2022